Liberty Global Reports Q4 and FY 2023 Results
Achieved full-year 2023 guidance (as updated) including operating company targets and Distributable Cash Flow (before unanticipated tax payment) Delivered stable... Read more.
OFS Credit Company Provides January 2024 Net Asset Value Update
CHICAGO–(BUSINESS WIRE)–OFS Credit Company, Inc. (NASDAQ: OCCI) (“OFS Credit,” the “Company,” “we,” “us” or “our”), an investment... Read more.
GCT Semiconductor and Concord Acquisition Corp III Announce Effectiveness of Registration Statement on Form S-4
Special Meeting of Stockholders Set for February 27, 2024 SAN JOSE, Calif. & NEW YORK–(BUSINESS WIRE)–GCT Semiconductor, Inc. (“GCT Semiconductor”... Read more.
AM Best Affirms Credit Ratings of Mercury General Corporation and Its Subsidiaries
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit... Read more.
The Law Offices of Frank R. Cruz Announces Investigation of Amplitude, Inc. (AMPL) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ:... Read more.
Red River Recognized as Public Sector Partner of the Year by Riverbed
Award honors Red River’s excellence in performance, innovation and implementation of Riverbed technology CHANTILLY, Va. & CLAREMONT, N.H.–(BUSINESS WIRE)–Red... Read more.
Preclinical Data on PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Immune Response
Research Published in NPJ Vaccines ATHENS, Ga. & MEMPHIS, Tenn.–(BUSINESS WIRE)–CyanVac LLC, a clinical-stage intranasal vaccine company developing... Read more.
Bending Spoons Closes a New Equity Financing Round, Raising $155 Million at a $2.55 Billion Post-money Valuation
MILAN–(BUSINESS WIRE)–Bending Spoons closes a new equity financing round. Durable Capital Partners LP joins existing investors Baillie Gifford, Cox Enterprises,... Read more.
Former Twilio Exec Launches Zocks, an AI-Powered Platform that Captures Industry Specific Insights from Client Conversations
Zocks can save companies millions of dollars in lost time by capturing important information from client meetings to accelerate record keeping and back office workflows.... Read more.
Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Lymphoma (AML) and High-Risk Myelodysplastic Syndromes (MDS)
Entering the clinic in the second half of 2024, KME-0584, an IRAK1/4/panFIt3 Inhibitor is a first in class investigational drug for relapsed/refractory AML and high-risk... Read more.